216 related articles for article (PubMed ID: 15864120)
1. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
King LM; Gainer JV; David GL; Dai D; Goldstein JA; Brown NJ; Zeldin DC
Pharmacogenet Genomics; 2005 Jan; 15(1):7-13. PubMed ID: 15864120
[TBL] [Abstract][Full Text] [Related]
2. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.
Lee CR; North KE; Bray MS; Couper DJ; Heiss G; Zeldin DC
Pharmacogenet Genomics; 2007 May; 17(5):349-58. PubMed ID: 17429317
[TBL] [Abstract][Full Text] [Related]
3. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
[TBL] [Abstract][Full Text] [Related]
4. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
[TBL] [Abstract][Full Text] [Related]
5. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.
Dai D; Zeldin DC; Blaisdell JA; Chanas B; Coulter SJ; Ghanayem BI; Goldstein JA
Pharmacogenetics; 2001 Oct; 11(7):597-607. PubMed ID: 11668219
[TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.
Smith HE; Jones JP; Kalhorn TF; Farin FM; Stapleton PL; Davis CL; Perkins JD; Blough DK; Hebert MF; Thummel KE; Totah RA
Pharmacogenet Genomics; 2008 Nov; 18(11):943-53. PubMed ID: 18769365
[TBL] [Abstract][Full Text] [Related]
8. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
[TBL] [Abstract][Full Text] [Related]
9. Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients.
Tzveova R; Naydenova G; Yaneva T; Dimitrov G; Vandeva S; Matrozova Y; Pendicheva-Duhlenska D; Popov I; Beltheva O; Naydenov C; Tarnovska-Kadreva R; Nachev G; Mitev V; Kaneva R
Biochem Genet; 2015 Dec; 53(11-12):319-33. PubMed ID: 26404779
[TBL] [Abstract][Full Text] [Related]
10. A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population.
Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Ivakin VE; Katargina LN; Kolesnikova OE
Dis Markers; 2008; 24(2):119-26. PubMed ID: 18219097
[TBL] [Abstract][Full Text] [Related]
11. Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
Genvigir FDV; Nishikawa AM; Felipe CR; Tedesco-Silva H; Oliveira N; Salazar ABC; Medina-Pestana JO; Doi SQ; Hirata MH; Hirata RDC
Pharmacotherapy; 2017 May; 37(5):535-545. PubMed ID: 28316087
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
[TBL] [Abstract][Full Text] [Related]
14. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
[TBL] [Abstract][Full Text] [Related]
15. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history.
Wang CP; Hung WC; Yu TH; Chiu CA; Lu LF; Chung FM; Hung CH; Shin SJ; Chen HJ; Lee YJ
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):346-52. PubMed ID: 20140850
[TBL] [Abstract][Full Text] [Related]
17. Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension.
Wu SN; Zhang Y; Gardner CO; Chen Q; Li Y; Wang GL; Gao PJ; Zhu DL
Ann Hum Genet; 2007 Jul; 71(Pt 4):519-25. PubMed ID: 17286575
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus.
Pucci L; Lucchesi D; Chirulli V; Penno G; Johansson I; Gervasi P; Del Prato S; Longo V
Am J Pharmacogenomics; 2003; 3(5):355-8. PubMed ID: 14575523
[TBL] [Abstract][Full Text] [Related]
19. CYP2C8 and CYP2J2 gene variations increase the risk of hypertensive intracerebral hemorrhage.
Li Y; You C; Liu Z; He F; Zhao F; Song X; Xie Z; Wei S; Yang Y; Wei H; Che F; Yu J
J Stroke Cerebrovasc Dis; 2023 Mar; 32(3):106974. PubMed ID: 36587509
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients.
Gervasini G; Luna E; Garcia-Pino G; Azevedo L; Mota-Zamorano S; José Cubero J
Curr Med Res Opin; 2018 Feb; 34(2):247-253. PubMed ID: 29022765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
